Cases 71 - 80 of 1,139
Eli Lilly and Company et al v. MSN Laboratories Private Limited et al
as 1:2023cv01277
Plaintiff:
Eli Lilly and Company, Incyte Corporation and Incyte Holdings Corporation
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Orion Corporation et al v. Hetero USA Inc. et al
as 1:2023cv01221
Plaintiff:
Orion Corporation, Bayer Consumer Care AG, Bayer Healthcare LLC and others
Defendant:
Hetero USA Inc., Hetero Labs Ltd., Unit-V and Hetero Labs Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al.
as 1:2023cv01103
Counter Defendant:
Bayer Intellectual Property GMBH
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Auson Pharmaceuticals, Inc. and Auson Pharmaceuticals Co., Ltd.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2023cv01015
Plaintiff:
Heron Therapeutics, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Galderma Laboratories, L.P. et al v. Apotex Inc. et al
as 1:2022cv00724
Plaintiff:
Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01008
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Lupin Ltd. et al
as 1:2023cv00964
Counter Defendant:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Zenara Pharma Private Limited
as 1:2023cv00924
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Zenara Pharma Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Aurobindo Pharma Limited
as 1:2023cv00923
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
